News

Michael J. Fox, 61, is set to receive an honorary Oscar Award this fall for his contribution to Parkinson’s research. The Academy of Motion Picture Arts selected him for the...

Elon Musk’s latest business venture, Neuralink, has the potential to change the way medical professionals manage movement disorders. But Neuralink’s competitor, Synchron, is racing ahead with its first human trial...

Elon Musk’s latest business venture is turning heads in the medical industry. While Musk is most well-known for his work with Tesla and SpaceX, the entrepreneur and investor is developing...

A new program launched by the Parkinson’s Foundation will help to make palliative care a standard practice across all Centers of Excellence in the United States. These are medical centers...

As the coronavirus and flu season collide, this upcoming fall and winter will be like none the world has ever seen. Here in the United States, it is important to...

Access to medicine is important. Drug regimens are part of treating many health conditions, and delays in taking drugs can have serious effects on health and well-being. Many people get...

The U.S. Food and Drug Administration (FDA) has approved the use of Abbott’s Patient Controller app on personal Apple smartphone devices. The app is designed to coordinate therapies that use...

Even after months of navigating life in the COVID-19 era, keeping up with new information and news can be overwhelming. Below are some of the latest developments surrounding COVID-19 for...

Many of us are overwhelmed by the amount of information available on COVID-19. Keeping up with all of the news can be challenging. Here are some of the top developments...

Our world is still changing every day because of COVID-19. Keeping up with all of the news can be challenging. Here are some of the top COVID-19 updates for people...

The 2020 Fatigue and Health survey has now closed. Thank you for your interest! We are excited to share the results with you soon.Exhaustion, tiredness, weariness... fatigue. We know chronic...

On March 19, the U.S. Food and Drug Administration (FDA) approved the testing of two drugs, chloroquine (hydroxychloroquine) and remdesivir, to treat people with COVID-19. The drugs have been given...

With all of the news circulating about the novel (new) coronavirus, it can be easy to feel overwhelmed or anxious. This is especially true if you are immune-compromised due to...

For those living with chronic health conditions, current news about the coronavirus (COVID-19) can be anxiety-inducing. We have questions and concerns about how the virus is transmitted, how it can...

Dr. Ray Dorsey is the David M. Levy Professor of Neurology and Director of the Center for Health + Technology at the University of Rochester. Through creative use of technology...

On December 3, 2019, the FDA granted a Breakthrough Device Designation for the RightEye Vision System to help with early diagnosis of Parkinson’s disease (PD).1 Depending on how well the...

Editor's Note: The Emma Watch was a prototype designed by Microsoft specifically made for someone with PD. Unfortunately, it is uncertain if a commercially available product will be made. Microsoft...

With no known cause, researchers continue to investigate how Parkinson’s disease (PD) develops in different kinds of people. Believed to be caused by a combination of environmental and genetic factors...

Near infrared light (NIr), a low level laser or LED (light emitting diode) is a new neuroprotective approach being tested in labs for use in treating Parkinson's disease and numerous...

More than 200 million Americans now own smartphones, among two billion users worldwide. Some people use them to make and take calls. Other users read email, while many watch videos...